Monthly cyclophosphamide pulses in the treatment of crescentic glomerulonephritis.
De La Torre
M
M
Service of Nephrology, Hospital Alarcos, Ciudad Real, Spain.
Alcázar
R
R
Urra
J M
JM
Caparrós
G
G
Alegre
R
R
Blanco
J
J
Nieto
J
J
Ferreras
I
I
D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000473:pathology; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone